Adicon Holdings (Adicon Holdings) Capex-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Adicon Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Adicon Holdings's Capital Expenditure for the three months ended in Dec. 2023 was $0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was $0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.

Adicon Holdings Capex-to-Revenue Historical Data

The historical data trend for Adicon Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicon Holdings Capex-to-Revenue Chart

Adicon Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Capex-to-Revenue

0.04

0.05

0.06

0.05

Adicon Holdings Quarterly Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Revenue	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Adicon Holdings's Capex-to-Revenue

For the Diagnostics & Research subindustry, Adicon Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adicon Holdings's Capex-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Adicon Holdings's Capex-to-Revenue falls into.

Adicon Holdings Capex-to-Revenue Calculation

Adicon Holdings's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-23.171)	/	461.868
	=	0.05

Adicon Holdings's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (0)	/	0
	=	N/A

Adicon Holdings (OTCPK:ADCNF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Adicon Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Adicon Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Adicon Holdings (Adicon Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (OTCPK:ADCNF) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

09860:Hong Kong

Address

No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN

Website

https://www.adicon.com.cn

Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.

Adicon Holdings (Adicon Holdings) Headlines

No Headlines